Cancer clinical trials have evolved rapidly in recent years as investigators integrate an expanding body of knowledge into the design and analysis of clinical trials. Coupled with an increased importance on efficiency and availability of large data warehouses, there is an even greater need for identifying and using appropriate statistical methodologies. The focus of Dr. Gregory Pond’s research interests is in the statistical methodologies and analysis of cancer clinical trials, with an aim to facilitate the translation of scientific discoveries into the clinic.
|2015 -||OICR Investigator II, Ontario Institute for Cancer Research (OICR).|
|2014 -||Associate Professor, Department of Oncology, McMaster University, Hamilton.|
|2011 -||Research Scientist, Escarpment Cancer Research Institute.|
|2008 -||Faculty Biostatistician, Ontario Clinical Oncology Group (OCOG).|
|2008 -||Associate Member, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton.|
|2008||PhD, Biostatistics, University of Toronto.|
|2007 - 2008||Senior Biostatistician, Industry.|
|2006||PStat, Accredited as Professional Statistician, Statistical Society of Canada.|
|2001 - 2007||Biostatistician, Princess Margaret Cancer Centre (PMCC).|
|2000 - 2001||Biostatistician, Mayo Clinic.|
|2000||MSc, Statistics, Simon Fraser University (SFU).|
- Elit LM, O’Leary EM, Pond GR, Seow HY.
Impact of wait times on survival for women with uterine cancer.
- J Clin Oncol. 2014 Jan 1;32(1):27-33. doi:10.1200/JCO.2013.51.3671. Epub 2013 Nov 25.
- Go to Impact of wait times on survival for women with uterine cancer.
- O’Leary E, Seow H, Julian J, Levine M, Pond GR.
Data collection in cancer clinical trials: Too much of a good thing?
- Clin Trials. 2013 Aug; 10(4):624-32.
- Go to Data collection in cancer clinical trials: Too much of a good thing?
- Pond GR, Abbasi S.
Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials.
- Clin Trials. 2011 Jun;8(3):260-9. doi: 10.1177/1740774511401764. Epub 2011 Apr 20.
- Go to Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials.
- Pond GR.
Statistical issues in the use of dynamic allocation methods for balancing baseline covariates.
- Br J Cancer. 2011 May 24;104(11):1711-5. doi: 10.1038/bjc.2011.157. Epub 2011 May 3.
- Go to Statistical issues in the use of dynamic allocation methods for balancing baseline covariates.
- Gan HK, Grothey A, Pond GR, Moore MJ, Siu LL, Sargent D.
Randomized Phase II Trials: Inevitable or Inadvisable?
- J Clin Oncol. 2010 May 20; 28(15):2641-7. doi: 10.1200/JCO.2009.26.3343. Epub 2010 Apr 20.
- Go to Randomized Phase II Trials: Inevitable or Inadvisable?